SkinHealth SystemsvsThermo Fisher Scientific

SKIN and TMO stock compared: price, dividend, valuation and results, from SEC filings.

SKIN

SkinHealth Systems Inc.

$13.15

Value –

-5.23%
SKIN's page

TMO

Thermo Fisher Scientific Inc

$691.79

Value $257B

+0.49%
TMO's page

Over the last year, with dividends, SKIN moved +935.4% and TMO +22.3%. Dividend yield: SKIN none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SKIN–

    TMO$257B

  • Revenue, 12 months

    SKIN$289M

    TMO$47.4B

    TMO is 164 times SKIN

  • Net income, 12 months

    SKIN-$18M

    TMO$7.1B

  • Operating margin

    SKIN2.4%

    TMO17.9%

    15.5 points apart

  • ROIC

    SKIN1.4%

    TMO8.2%

    6.8 points apart

  • P/E

    SKIN–

    TMO36.3

  • Dividend yield

    SKIN0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    SKIN-53.0%

    TMO+10.0%

    63.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

SKIN-53.0%

TMO+10.0%

05010020222023202420252026
Returns by period
PeriodSKINWith dividendsTMOWith dividends
1 year since November 17, 2025+935.4%Price +935.4%+22.3%Price +21.8%
3 years since November 17, 2023+481.9%+79.9% a yearPrice +481.9%+49.6%+14.4% a yearPrice +48.1%
5 years since November 17, 2021-53.0%-14.0% a yearPrice -53.0%+10.0%+1.9% a yearPrice +8.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SKINSkinHealth SystemsTMOThermo Fisher Scientific

Valuation

SKINTMO
Valuation
Price$13.15$691.79
Market value–$257B
Enterprise value (EV)–$292B
P/E–36.3
P/E, 5-year median–32.7
P/B–4.7
EV/EBIT–34.5
Free cash flow yield–3.0%

Results and growth

SKINTMO
Results and growth
Revenue, 12 months$289M$47.4B
Net income, 12 months-$18M$7.1B
Free cash flow, 12 months$23M$7.6B
Earnings per share, 12 months-$2.62$18.96
Revenue growth, year on year-10.0%3.9%
Revenue growth a year, past+20.4%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

SKINTMO
Margins and returns on capital
Gross margin67.2%–
Operating margin2.4%17.9%
Net margin-6.3%14.9%
ROIC1.4%8.2%
ROE-31.2%13.4%

Balance sheet

SKINTMO
Balance sheet
Cash$112M$6.1B
Total debt$264M$41.4B
Net debt / EBITDA12.13.7
Interest cover0.3×5.5×

Dividends and buybacks

SKINTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SKIN or TMO

Didn't find what you were looking for?

Ask us
How did SKIN and TMO stock do over the last 5 years?

Since November 17, 2021, SKIN's price moved -53.0% and TMO's +8.4%. With dividends: SKIN -53.0% (-14.0% a year), TMO +10.0% (+1.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, SKIN or TMO?

The dividend yield at today's price is none for SkinHealth Systems and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, SkinHealth Systems or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -6.3% for SkinHealth Systems and 14.9% for Thermo Fisher Scientific, and the operating margin 2.4% and 17.9%. Revenue was $289M and $47.4B.

Which is the better investment, SkinHealth Systems or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.